Brain metastasis is a kind of cancer. Cancers that have spread to the brain include breast cancer, lung cancer, melanoma, renal cell carcinoma, etc. Brain metastases mostly occur in the brain, and can be effectively relieved by chemotherapy, radiation therapy and other treatment methods.
This report contains market size and forecasts of Brain Metastasis Therapeutic in Global, including the following market information:
Global Brain Metastasis Therapeutic Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Brain Metastasis Therapeutic market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Corticosteroids Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Brain Metastasis Therapeutic include F. Hoffmann-La Roche Ltd., GlaxoSmithKline, Eli Lilly & Company, Merck & Co., Inc., Bayer AG, AngioChem Inc., Novartis AG, Pfizer Inc. and AstraZeneca and etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Brain Metastasis Therapeutic companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Brain Metastasis Therapeutic Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Brain Metastasis Therapeutic Market Segment Percentages, by Type, 2021 (%)
Corticosteroids
Anticonvulsants
Targeted Therapy
Chemotherapy
Radiation Therapy
Global Brain Metastasis Therapeutic Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Brain Metastasis Therapeutic Market Segment Percentages, by Application, 2021 (%)
Cancer Research Centers
Cancer Hospitals
Clinics
Others
Global Brain Metastasis Therapeutic Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Brain Metastasis Therapeutic Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Brain Metastasis Therapeutic revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Brain Metastasis Therapeutic revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
F. Hoffmann-La Roche Ltd.
GlaxoSmithKline
Eli Lilly & Company
Merck & Co., Inc.
Bayer AG
AngioChem Inc.
Novartis AG
Pfizer Inc.
AstraZeneca
Sanofi